Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal Timing of Tenofovir in Pregnant Women with Chronic HBV
NCT02510963Unknown
- Sponsor
- First Affiliated Hospital of Xi'an Jiaotong University
- Start
- Nov 2015
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of tenofovir disoproxil fumarate in hepatitis B (HBV) (3 arms), sponsored by First Affiliated Hospital of Xi'an Jiaotong University. Primary endpoint: HBV DNA load in serum at 40 weeks. Status: unknown.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT02510963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02510963.